The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...
Botox is everywhere right now. It’s nearly impossible to walk down a city block or through a suburban strip mall without seeing signs in med spas or even hair salon windows advertising it—sometimes at ...
Allergan Inc. is banking on other uses for its flagship Botox drug as well as new products to keep up the growth that’s made the company a standout on Wall Street. “This really is a product-based ...
NEW YORK (AP) — Valeant Pharmaceuticals has teamed up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion. Valeant said Monday that it intends to ...
Pyott: “This has been the best year for R&D approvals ever” Irvine drug maker Allergan Inc. has built itself into a multibillion dollar company by going after, and even creating, new markets. Now it’s ...
Jan 4 (Reuters) - A federal judge on Wednesday said Botox maker AbbVie's ABBV.N Allergan unit can move ahead with its lawsuit accusing Revance Therapeutics RVNC.O of taking its confidential data to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results